InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor Mesutoclax for Myelodysplastic Syndromes in China#InnoCare #Announces…
Tag: Clinical
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in…
Intellia reports progress in Phase 3 clinical trials
Intellia reports progress in Phase 3 clinical trials#Intellia #reports #progress #Phase #clinical #trials
Revolution Medicines' SWOT analysis: stock shows promise amid clinical progress
Revolution Medicines' SWOT analysis: stock shows promise amid clinical progress#Revolution #Medicines039 #SWOT #analysis #stock #shows #promise…
Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting
Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting#Abstracts #KelunBiotech039s #Clinical #Studies…
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial…
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with…
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson's disease
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson's disease#patients…
CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript)
CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript) #CytomX #Therapeutics #CTMX #CX2051…
New Patient-Reported Outcomes from UGN-102 Clinical Trials Show the Investigational Treatment Did Not Adversely Affect Functionality, Symptom Burden, and Quality of Life in Patients with LG-IR-NMIBC
New Patient-Reported Outcomes from UGN-102 Clinical Trials Show the Investigational Treatment Did Not Adversely Affect Functionality,…
New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with…
Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancer
Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients…
Oncolytics Biotech ® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital
Oncolytics Biotech ® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with…
Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis
Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis#Remegen…
Autonomix to begin U.S. clinical studies for FDA approval
Autonomix to begin U.S. clinical studies for FDA approval#Autonomix #U.S #clinical #studies #FDA #approval
Takeda & Protagonist: Rusfertide Clinical Success Bolsters Investment Returns
Takeda & Protagonist: Rusfertide Clinical Success Bolsters Investment Returns #Takeda #amp #Protagonist #Rusfertide #Clinical #Success #Bolsters…
Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical &…
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on…
Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive
Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive #Theravance #Biopharma #Clinical #Progress #Attractive
Sonida Senior Living Advances Clinical Excellence with August Health
Sonida Senior Living Advances Clinical Excellence with August Health#Sonida #Senior #Living #Advances #Clinical #Excellence #August #Health